MoneyWorks4Me

The company witnessed a 10.94% growth in the revenue at Rs. 1559.88 millions for the quarter ended September 2023 as compared to Rs. 1406.12 millions during the year-ago period.The Company has registered profit of Rs. 276.54  millions for the quarter ended September 2023, a growth of 16.62%  over Rs. 237.12 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 398.42 millions from the corresponding previous quarter of 345.93 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1559.88 1406.12 10.94 2916.07 2640.83 10.42 5103.09 4720.79 8.10
Other Income 86.95 56.85 52.95 163.86 121.80 34.53 224.84 99.98 124.88
PBIDT 398.42 345.93 15.17 682.48 580.00 17.67 1116.50 1054.68 5.86
Interest 3.94 1.39 183.45 8.09 5.50 47.09 20.29 14.51 39.83
PBDT 394.48 344.54 14.49 674.39 574.50 17.39 1096.21 1040.17 5.39
Depreciation 25.80 24.22 6.52 51.25 44.91 14.12 91.66 80.88 13.33
PBT 368.68 320.32 15.10 623.14 529.59 17.66 1004.55 959.29 4.72
TAX 92.14 83.20 10.75 156.47 142.34 9.93 275.56 265.74 3.70
Deferred Tax 6.04 1.65 266.06 15.27 1.39 998.56 15.86 7.20 120.28
PAT 276.54 237.12 16.62 466.67 387.25 20.51 728.99 693.55 5.11
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 25.54 24.60 3.82 23.40 21.96 6.56 21.88 22.34 -2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..